Efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2-positive early breast cancer and tumors ≤ 2 cm: A meta-analysis of the randomized trastuzumab trials.
Journal of Clinical Oncology.
Times cited: 39
Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis.
Times cited: 791